Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study.

Turki Abdulaziz AlthunianAnthonius de BoerRolf H H GroenwoldKatrien O RengerinkPatrick C SouvereinOlaf H Klungel

Published in: Pharmacoepidemiology and drug safety (2020)

The results of this study provide supportive evidence to the effectiveness of rivaroxaban and adds knowledge on the usefulness of emulating a non-inferiority trial to assess drug effectiveness.

Keyphrases

venous thromboembolism
atrial fibrillation
randomized controlled trial
healthcare
systematic review
pulmonary embolism
palliative care
clinical trial
study protocol
emergency department
quality improvement
clinical practice
drug induced